These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters. Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650 [TBL] [Abstract][Full Text] [Related]
3. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis. Robbie LA; Booth NA; Croll AM; Bennett B Thromb Haemost; 1993 Aug; 70(2):301-6. PubMed ID: 8236139 [TBL] [Abstract][Full Text] [Related]
4. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site. Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727 [TBL] [Abstract][Full Text] [Related]
5. Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components. Colucci M; Paramo JA; Stassen JM; Collen D J Clin Invest; 1986 Jul; 78(1):138-44. PubMed ID: 3088040 [TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated expression and packaging of tissue-type plasminogen activator in megakaryocytic cells. Chuang JL; Schleef RR Thromb Haemost; 2001 Jun; 85(6):1079-85. PubMed ID: 11434688 [TBL] [Abstract][Full Text] [Related]
7. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis. van Giezen JJ; Boon GI; Jansen JW; Bouma BN Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851 [TBL] [Abstract][Full Text] [Related]
9. Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator. Flight SM; Masci PP; Lavin MF; Gaffney PJ Blood Coagul Fibrinolysis; 2006 Jul; 17(5):417-20. PubMed ID: 16788320 [TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator. Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178 [TBL] [Abstract][Full Text] [Related]
11. The role of the finger domain of tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in initiation and progression of thrombolysis. Stringer HA; van Swieten P; Horrevoets AJ; Smilde A; Pannekoek H Thromb Haemost; 1994 Dec; 72(6):900-5. PubMed ID: 7740461 [TBL] [Abstract][Full Text] [Related]
12. Inactivation of plasminogen activator inhibitor-1 accelerates thrombolysis of a platelet-rich thrombus in rat mesenteric arterioles. Rupin A; Martin F; Vallez MO; Bonhomme E; Verbeuren TJ Thromb Haemost; 2001 Dec; 86(6):1528-31. PubMed ID: 11776323 [TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma. Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286 [TBL] [Abstract][Full Text] [Related]
14. Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA. Colucci M; D'Aprile AM; Italia A; Gresele P; Morser J; Semeraro N Thromb Haemost; 2001 Apr; 85(4):661-6. PubMed ID: 11341502 [TBL] [Abstract][Full Text] [Related]
15. A reconstituted dilute blood clot lysis assay for the medium throughput screening of thrombolytic compounds. Gadbut AP; Schullek JR; Hanel AM; MacAllan DR Anal Biochem; 1999 May; 270(1):24-32. PubMed ID: 10328761 [TBL] [Abstract][Full Text] [Related]
16. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes. Lijnen HR; Wagner EF; Collen D Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597 [TBL] [Abstract][Full Text] [Related]
17. Reactivated recombinant plasminogen activator inhibitor-1 (rPAI-1) effectively prevents thrombolysis in vivo. Vaughan DE; Declerck PJ; Van Houtte E; De Mol M; Collen D Thromb Haemost; 1992 Jul; 68(1):60-3. PubMed ID: 1514173 [TBL] [Abstract][Full Text] [Related]
18. Serpin-resistant mutants of human tissue-type plasminogen activator. Madison EL; Goldsmith EJ; Gerard RD; Gething MJ; Sambrook JF Nature; 1989 Jun; 339(6227):721-4. PubMed ID: 2500599 [TBL] [Abstract][Full Text] [Related]